Ji-Hun Son is now serving in a new board position at Hugel, Inc.

Jul 07, 2018
Board and Executive Moves
Background Information
Co-Chairman & Chief Executive Officer at Hugel, Inc.
Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.